MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
11.14
+0.03 (0.27%)
At close: May 12, 2025, 4:00 PM
11.14
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
MBX Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MBX Biosciences stock have an average target of 37.4, with a low estimate of 30 and a high estimate of 44. The average target predicts an increase of 235.73% from the current stock price of 11.14.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 10, 2025.
Analyst Ratings
The average analyst rating for MBX Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +241.11% | Apr 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +294.97% | Apr 10, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +214.18% | Oct 8, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +169.30% | Oct 8, 2024 |
| Stifel | Stifel | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +259.07% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.83
from -5.82
EPS Next Year
-2.79
from -2.83
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.75 | -2.28 | -2.48 |
| Avg | -2.83 | -2.79 | -3.10 |
| Low | -2.97 | -3.12 | -3.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.